HST Global (HSTC) 10-K 2 Apr 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Mar. 28, 2018	Jun. 30, 2017
Document and Entity Information:
Entity Registrant Name	HST Global, Inc.
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Amendment Flag	false
Entity Central Index Key	797,564
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		36,719,854
Entity Public Float			$ 0.1
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Trading Symbol	hstc

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)		Dec. 31, 2017	Dec. 31, 2016
Current Assets
Cash and cash equivalents		$ 291	$ 465
Total Current Assets		291	465
Total Assets		291	465
Current Liabilities
Accounts payable and accrued expenses		4,688	25,219
Accounts payable and accrued expenses - related parties		505,959	505,959
Accrued officer compensation		990,000	870,000
Accrued related party interest		35,748	35,748
Notes payable - related party		1,351,369	1,321,669
Total Current Liabilities		3,192,898	3,027,980
Total Liabilities		3,192,898	3,027,980
Stockholders' Deficit
Common stock	[1]	36,720	36,720
Additional paid-in capital		2,384,824	2,384,824
Accumulated deficit		(5,614,151)	(5,449,059)
Total Stockholders' Deficit		(3,192,607)	(3,027,515)
Total Liabilities and Stockholders' Deficit		$ 291	$ 465
[1]	100,000,000 shares authorized, at $0.001 par value, 36,719,854 and 36,719,854 shares issued and outstanding, respectively

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Operating Expenses:
Consulting	$ 120,000	$ 120,000
General and administrative	32,995	17,274
Total Operating Expenses	152,995	137,274
Net Loss From Operations	(152,995)	(137,274)
Other Income (Expense)
Interest expense	(35,748)	(35,748)
Gain on forgiveness of accounts payable	(23,651)
Total Other Income (Expense)	(12,097)	(35,748)
Net Loss	$ (165,092)	$ (173,022)
Loss Per Share: Basic And Diluted - Common	$ 0	$ 0
Weighted Average Shares Outstanding: Basic And Diluted - Common	36,719,854	36,719,854

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated deficit	Total Stockholders' Deficit
Balance Beginning of Period at Dec. 31, 2014		$ 36,720	$ 2,384,824	$ (5,080,242)	$ (2,658,698)
Balance Beginning of Period - Shares at Dec. 31, 2014		36,719,854
Net Loss				(195,795)	(195,795)
Balance End of Period at Dec. 31, 2015		$ 36,720	2,384,824	(5,276,037)	(2,854,493)
Balance End of Period - Shares at Dec. 31, 2015		36,719,854
Net Loss	$ (173,022)			(173,022)	(173,022)
Balance End of Period at Dec. 31, 2016		$ 36,720	2,384,824	(5,449,059)	(3,027,515)
Balance End of Period - Shares at Dec. 31, 2016		36,719,854
Net Loss	$ (165,092)			(165,042)	(165,042)
Balance End of Period at Dec. 31, 2017		$ 36,720	$ 2,384,824	$ (5,614,151)	$ (3,192,602)
Balance End of Period - Shares at Dec. 31, 2017		36,719,854

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flows From Operating Activities:
Net Loss	$ (165,092)	$ (173,022)
Adjustments to reconcile net loss to net cash used by operating activities:
Gain on forgiveness of accounts payable	(23,651)
Changes in operating assets and liabilities:
Change in Accounts payable and accrued expenses	(3,121)	(4,656)
Change in Accrued officer compensation	120,000	120,000
Change in Accrued related party interest	35,748	35,748
Net Cash used in Operating Activities	(29,874)	(21,930)
Cash Flows From Financing Activities:
Proceeds from notes payable - related party	29,700	22,200
Net cash provided by financing activities	29,700	22,200
Net Decrease in cash	(174)	270
Cash at Beginning of Period	465	195
Cash at End of Period	$ 291	$ 465

Note 1 - Organization and Princ

Note 1 - Organization and Principal Activities	12 Months Ended
	Dec. 31, 2017
Notes
Note 1 - Organization and Principal Activities	NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations. Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia. HST Global, Inc. is an integrated Health and Wellness Biotechnology company that is developing and/or acquiring a network of Wellness Centers worldwide with the primary focus on homeopathic and alternative treatments of late stage cancer and other life threatening diseases. In addition, the Company intends to acquire innovative products for the treatment of life threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer and/or life threatening diseases.

Note 2 - Significant Accounting

Note 2 - Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Notes
Note 2 - Significant Accounting Policies	NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K. Princliples of Consolidation The consolidated financial statements include our wholly-owned subsidiary. Intercompany balances and transactions have been eliminated. Accounting Method The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. Income Taxes The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, " Income Taxes The Company applies the provisions of ASC 740, “ Accounting for Uncertainty in Income Taxes Basic and Diluted Loss Per Share The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti dilutive. The Company had no common stock equivalents outstanding as of December 31, 2017 and 2016. Stock-Based Compensation The Company adopted ASC 718, “Stock Compensation”, December 31 Fair Value of Financial Instruments The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value. The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. Recently Issued Accounting Pronouncements Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

Note 3 - Going Concern

Note 3 - Going Concern	12 Months Ended
	Dec. 31, 2017
Notes
Note 3 - Going Concern	NOTE 3 – GOING CONCERN The Company’s consolidated financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business within one year after the date these financial statements were issued Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the money it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities Disclosure	12 Months Ended
	Dec. 31, 2017
Notes
Accounts Payable and Accrued Liabilities Disclosure	NOTE 4 – ACCOUNTS PAYABLE AND ACCURED EXPENSES – RELATED PARTIES Accounts payable and accrued expenses- related parties consist of the following at December 31, 2017 and 2016: December 31, 2017 December 31, 2016 The Health Network, Inc. $365,462 $365,462 Ronald Howell $43,770 $43,770 Eric Clemons $96,727 $96,727 Total $505,959 $505,959 Please see Note 6 for further explanation of these liabilities.

Note 4 - Notes Payable - Relate

Note 4 - Notes Payable - Related Parties	12 Months Ended
	Dec. 31, 2017
Notes
Note 4 - Notes Payable - Related Parties	NOTE 5 – NOTES PAYABLE – RELATED PARTIES During the year ended December 31, 2017, the Company received $29,700 in additional cash loans from various related parties. During the year ended December 31, 2016, the Company received $22,200 in additional cash loans from various related parties. Total related party notes payable as of December 31, 2017 were $1,351,369. Of this total, $595,800 of related party notes payable is unsecured, bears interest at 6 percent per annum, and is due on demand; Also of this total, $200,000 is unsecured, bears a flat owed interest amount of $46,000, and is due on demand. The remaining $555,569 of related party notes payable is unsecured, bears no interest, and is due on demand. Included in the related party notes payable balance is a $50,000 penalty fee associated with one of its related party notes due to nonpayment.

Note 5 - Related Party Transact

Note 5 - Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Notes
Note 5 - Related Party Transactions	NOTE 6 – RELATED PARTY TRANSACTIONS Executive Offices The Company's executive offices are located at 150 Research Dr., Hampton VA. These offices are leased by The Health Network, Inc. ("THN"), of which Ron Howell is President. THN allows the Company to use the office space without a formal sublease or rental agreement. At December 31, 2017 and 2016 Consulting Agreements The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010. Mr. Howell received 714,286 shares of common stock valued at $120,000 as a partial payment for amounts owed under this agreement. The consulting agreement may be terminated at will by the Company. The Company intends to The Company entered into a consulting agreement with Eric Clemons, a shareholder of the Company, whereby the Company agreed to pay Mr. Clemons $10,000 per month for consulting services through December 2009. This employment agreement carried the provision that it could be extended beyond this date upon mutual agreement by both parties and that the agreement could be canceled by the Company at any time after that date. The Company continued to accrue amounts owed under this agreement through July of 2010. The balance owed to Mr. Clemons at December 31, 2017

Note 7 - Income Taxes

Note 7 - Income Taxes	12 Months Ended
	Dec. 31, 2017
Notes
Note 7 - Income Taxes	NOTE 7 – INCOME TAXES The Company follows ASC 740, under which deferred income taxes reflect the net effect of (a) temporary difference between carrying amounts of assets and liabilities for financial purposes and the amounts used for income tax reporting purposes, and (b) net operating loss carry-forwards. No net provision for refundable Federal income tax has been made in the accompanying statement of loss because no recoverable taxes were paid previously. Similarly, no deferred tax asset attributable to the net operating loss carry-forward has been recognized, as it is not deemed likely to be realized. The cumulative tax effect at the expected rate of 34 percent of significant items comprising our net deferred tax amount is as follows: Year Ended December 31, 2017 Year Ended December 31, 2016 Income tax benefit attributable to: Net operating loss $ (56,131) $ (58,827) Common stock issued for services - - Change in valuation allowance 56,131 58,827 Net refundable amount $ - $ - The cumulative tax effect at the expected rate of 34 percent of significant items comprising our net deferred tax amount is as follows: December 31, 2017 December 31, 2016 Deferred tax asset attributable to: Net operating loss carry forwards $ (1,934,445) $ (1,887,314) Common stock issued for services 184,072 184,072 Valuation allowance 1,759,373 1,703,242 Net deferred tax asset $ - $ - The Company’s zero percent effective tax rate for each year, as compared to the 34 percent statutory rate, results from non-deductible stock based compensation and the change in valuation allowance. At December 31, 2017, the Company had an unused net operating loss carry-forward of approximately $1,943,445 that is available to offset future taxable income; the loss carry-forward will begin to expire in 2027.

Note 6 - Subsequent Events

Note 6 - Subsequent Events	12 Months Ended
	Dec. 31, 2017
Notes
Note 6 - Subsequent Events	NOTE 8 – SUBSEQUENT EVENTS In accordance with ASC 855, Company management reviewed all material events through the date of this report and determined that there are no material subsequent events to report.

Note 2 - Significant Accounti14

Note 2 - Significant Accounting Policies: Basis of Presentation (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Basis of Presentation	Basis of Presentation The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K.

Note 2 - Significant Accounti15

Note 2 - Significant Accounting Policies: Princliples of Consolidation (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Princliples of Consolidation	Princliples of Consolidation The consolidated financial statements include our wholly-owned subsidiary. Intercompany balances and transactions have been eliminated.

Note 2 - Significant Accounti16

Note 2 - Significant Accounting Policies: Accounting Method (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Accounting Method	Accounting Method The Company’s financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end.

Note 2 - Significant Accounti17

Note 2 - Significant Accounting Policies: Use of Estimates (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Note 2 - Significant Accounti18

Note 2 - Significant Accounting Policies: Cash and Cash Equivalents (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

Note 2 - Significant Accounti19

Note 2 - Significant Accounting Policies: Income Taxes (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, " Income Taxes The Company applies the provisions of ASC 740, “ Accounting for Uncertainty in Income Taxes

Note 2 - Significant Accounti20

Note 2 - Significant Accounting Policies: Basic Loss Per Share (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Basic Loss Per Share	Basic and Diluted Loss Per Share The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti dilutive. The Company had no common stock equivalents outstanding as of December 31, 2017 and 2016.

Note 2 - Significant Accounti21

Note 2 - Significant Accounting Policies: Stock-based Compensation (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Stock-based Compensation	Stock-Based Compensation The Company adopted ASC 718, “Stock Compensation”, December 31

Note 2 - Significant Accounti22

Note 2 - Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value. The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability.

Note 2 - Significant Accounti23

Note 2 - Significant Accounting Policies: Recently Issued Accounting Pronouncements (Policies)	12 Months Ended
	Dec. 31, 2017
Policies
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

Accounts Payable and Accrued 24

Accounts Payable and Accrued Liabilities Disclosure: Schedule of Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Tables/Schedules
Schedule of Accounts Payable and Accrued Liabilities	December 31, 2017 December 31, 2016 The Health Network, Inc. $365,462 $365,462 Ronald Howell $43,770 $43,770 Eric Clemons $96,727 $96,727 Total $505,959 $505,959

Note 7 - Income Taxes_ Schedule

Note 7 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)	12 Months Ended
	Dec. 31, 2017
Tables/Schedules
Schedule of Components of Income Tax Expense (Benefit)	Year Ended December 31, 2017 Year Ended December 31, 2016 Income tax benefit attributable to: Net operating loss $ (56,131) $ (58,827) Common stock issued for services - - Change in valuation allowance 56,131 58,827 Net refundable amount $ - $ -

Note 7 - Income Taxes_ Schedu26

Note 7 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Tables/Schedules
Schedule of Deferred Tax Assets and Liabilities	December 31, 2017 December 31, 2016 Deferred tax asset attributable to: Net operating loss carry forwards $ (1,934,445) $ (1,887,314) Common stock issued for services 184,072 184,072 Valuation allowance 1,759,373 1,703,242 Net deferred tax asset $ - $ -

Accounts Payable and Accrued 27

Accounts Payable and Accrued Liabilities Disclosure: Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Details
Due to Affiliate, Current	$ 365,462	$ 365,462	$ 365,462
Due to Officers or Stockholders, Current	920,000	800,000	43,770
Due to Other Related Parties, Current	70,000	70,000	96,727
Accounts payable and accrued expenses - related parties	$ 505,959	$ 505,959	$ 505,959

Note 4 - Notes Payable - Rela28

Note 4 - Notes Payable - Related Parties (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Details
Proceeds from notes payable - related party	$ 29,700	$ 22,200
Notes payable - related party	$ 1,351,369	$ 1,321,669

Note 5 - Related Party Transa29

Note 5 - Related Party Transactions (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Details
Due to Affiliate, Current	$ 365,462	$ 365,462	$ 365,462
Due to Officers or Stockholders, Current	920,000	800,000	43,770
Due to Other Related Parties, Current	$ 70,000	$ 70,000	$ 96,727

Note 7 - Income Taxes_ Schedu30

Note 7 - Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Tax Expense (Benefit), Continuing Operations
Current Income Tax Expense (Benefit)	$ (56,131)	$ (58,827)
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	$ 56,131	$ 58,827

Note 7 - Income Taxes_ Schedu31

Note 7 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Deferred Tax Assets, Net
Deferred Tax Assets, Operating Loss Carryforwards	$ (1,934,445)	$ (1,887,314)
Deferred Tax Assets, Valuation Allowance	$ 1,759,373	$ 1,703,242